Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Receivables (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Receivables for 6 consecutive years, with $25.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 2.71% year-over-year to $25.6 million, compared with a TTM value of $25.6 million through Dec 2025, up 2.71%, and an annual FY2025 reading of $25.6 million, up 2.71% over the prior year.
  • Receivables was $25.6 million for Q4 2025 at Viemed Healthcare, down from $27.4 million in the prior quarter.
  • Across five years, Receivables topped out at $27.4 million in Q3 2025 and bottomed at $12.1 million in Q2 2021.
  • Average Receivables over 5 years is $19.5 million, with a median of $17.9 million recorded in 2023.
  • The sharpest move saw Receivables fell 13.99% in 2021, then soared 51.25% in 2024.
  • Year by year, Receivables stood at $12.8 million in 2021, then rose by 19.93% to $15.4 million in 2022, then grew by 19.98% to $18.5 million in 2023, then soared by 35.01% to $24.9 million in 2024, then increased by 2.71% to $25.6 million in 2025.
  • Business Quant data shows Receivables for VMD at $25.6 million in Q4 2025, $27.4 million in Q3 2025, and $26.5 million in Q2 2025.